четверг, 25 августа 2016 г.

Brief-L S Starrett Co announces fiscal 2016 Q4 and Fy results

Brief-L S Starrett Co announces fiscal 2016 Q4 and Fy results


WASHINGTON, Aug 24 Pharmaceutical company Mylan NV has won a round in its fight with Teva Pharmaceutical Industries Ltd at the U.S. Patent and Trademark Office, which said on Wednesday that two patents for the multiple sclerosis drug Copaxone sold by Teva were, after a review process, considered unpatentable.



from Biotech News